Work

ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome

Year: 2019

Type: article

Source: Pharmacology Biochemistry and Behavior

DOI: 10.1016/j.pbb.2019.172796

Authors: Walter E. Kaufmann, Jeffrey Sprouse, Nell Rebowe, Taleen Hanania, Daniel Klamer, Christopher U. Missling

Institutions: Emory University, Anavex Life Sciences Corp. (United States), Psychogenics (United States)

Language: English

Topic: Genetics and Neurodevelopmental Disorders

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2989333414

FWCI: 3.005

Cites: 61

Cited by: 54

Related to: 10